Back to search

France· FR:68106914

DEXOCOL 1 mg/mL, collyre en solution

A medicinal product containing phosphate sodique de dexaméthasone, registered in France by HORUS PHARMA, on the national reimbursement list.

Reimbursed in France (Assurance maladie)

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedDEXOCOL 1 mg/mL, collyre en solutionATC—REGISTER NO.FR:68106914PACKS LISTED1CHECKEDSeptember 12, 2026

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
PHOSPHATE SODIQUE DE DEXAMÉTHASONE
Manufacturer
HORUS PHARMA
Country
France (FR)
ATC code
—
Reimbursed
Yes
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • cip13
    3400930179734
    1 flacon polyéthylène basse densité (PEBD) de 6 mL avec embout compte-gouttes polyéthylène haute densité (PEHD) et silicone
    EUR 6.77

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Phosphate sodique de dexaméthasone in 17 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All phosphate sodique de dexaméthasone products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

  • Austria · Dexamethason Hcs, Dexamethason Kalceks
  • Belgium · Darazon, Dexalis
  • Bulgaria · Dexanova, Дeксаметазон Крка
  • Cyprus · Axium-Opto, Decadron
  • Czechia · Dexamed, Dexamethasone Fmk
  • Germany · Dexa, Dexa Edo
  • Denmark · Axiumopto, Dexacur
  • Estonia · Caltrixan, Dexamethason Krka
  • Spain · Amexxine, Dexafree
  • Finland · Axiumopto, Dexacur
  • United Kingdom (Northern Ireland) · Dexafree, Dexamethason Glenmark Pharmaceuticals Europe
  • Greece · Amelinor, Axium
  • Croatia · Darazur, Deksametazon Kalceks
  • Hungary · Darazur, Dexamethasone Kalceks
  • Ireland · Dexafree, Dexamethasone Activase Pharmaceuticals
  • Iceland · Dexametason Abcur, Dexamethason Krka
  • Italy · Amexzur, Cortmuper
  • Liechtenstein · Neofordex, Ozurdex
  • Lithuania · Dexamethason Krka, Dexamethasone Kalceks
  • Luxembourg · Dexalis, Dexamethasone Kalceks
  • Latvia · Dexamethason Krka, Dexamethasone Kalceks
  • Malta · Axium-Opto, Decadron
  • Netherlands · Axium-Opto, Dexamethason
  • Norway · Dexacur, Dexametason Abcur
  • Poland · Covexan, Darazur
  • Portugal · Amexzur, Decadron
  • Romania · Dexametazonă Fosfat Krka, Dexametazona Krka
  • Sweden · Axiumopto, Baxil
  • Slovenia · Deksametazon Krka, Deksametazon Medochemie
  • Slovakia · Amexxine, Dexametazón Krka

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e662728d-0af4-4dfe-ac2a-444c8823dc2a
GET /v1/drugs/e662728d-0af4-4dfe-ac2a-444c8823dc2a?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "68106914",
  "date_amm": "2019-05-09",
  "type_amm": "Procédure décentralisée",
  "numero_ue": null,
  "substance": "PHOSPHATE SODIQUE DE DEXAMÉTHASONE",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "collyre en solution",
  "voies_administration": "ophtalmique",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}

See everything about phosphate sodique de dexaméthasone.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.